Significant Ownership of David E. Lazar

Signature - Title
/s/ David E. Lazar - David E. Lazar
Location
Panama City
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by David E. Lazar.

Follow Filing Activity

Follow David E. Lazar and return when a new Schedule 13D/G filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Significant Ownership of David E. Lazar

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
INDP Indaptus Therapeutics, Inc. Common Stock, $0.01 par value 48% $949,440 -$50,110,560 2,064,000 -98% Lazar David E. 23 Mar 2026
MINM FiEE, Inc. Common Stock, $0.01 par value 35% $308,248 2,802,254 -63% Lazar David E. 18 Feb 2025
MTNB Matinas BioPharma Holdings, Inc. Common Stock, par value $0.0001 per share 9.8% $517,750 545,000 Lazar David E. 15 Aug 2025
UUU Universal Safety Products, Inc. Common Stock, par value $0.01 per share 6.8% $799,184 156,396 Lazar David E. 16 Jan 2026
KALA KALA BIO, Inc. Common Stock, $0.001 par value 5.2% $27,522,000 49,500,000 David E. Lazar 30 Jan 2026
NBY NovaBay Pharmaceuticals, Inc. Common Stock, $0.01 par value 5% $36,028,320 +$27,556,589 6,388,000 +325% David E. Lazar 21 Oct 2025
CYCC Cyclacel Pharmaceuticals, Inc. Common Stock, $0.001 par value 0% $0 -$41,481 0 -100% Lazar David E. 05 Aug 2025

Schedules 13D/G Reported by David E. Lazar:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored